Global AIDS Response: Challenges and Resilience
- Here's a breakdown of the key numbers and data points from the provided text:
- * 9,157 thousand: The number of deaths from AIDS-related diseases in 2024, the lowest in 32 years. (This is equivalent to 9,157,000 deaths).
Here’s a breakdown of the key numbers and data points from the provided text:
* 9,157 thousand: The number of deaths from AIDS-related diseases in 2024, the lowest in 32 years. (This is equivalent to 9,157,000 deaths).
* 100%: Effectiveness of lenacapavir for HIV prevention in cis women (based on clinical studies).
* 96%: Effectiveness of lenacapavir for HIV prevention in trans people, cis gay men, and cis men who have sex with men (based on clinical studies).
* 50,000: The estimated number of infections that could be prevented in three years if long-acting injectable medicines were provided to 2 million people at high risk.
* 2 million: The number of people at high risk who would need to receive long-acting injectable medicines to possibly prevent 50,000 infections over three years.
* R$4,000: The average price per dose of the long-acting injectable medicine (in Brazilian Real).
* 2.5: The number of minimum wages in Brazil equivalent to the cost of one dose of the medicine.
* 2026-2031: The timeframe for the next Global AIDS Strategy being approved this week in Brazil.
* 57th: The meeting number of the UNAIDS Program Coordination Board being hosted in Brazil.
